nodes	percent_of_prediction	percent_of_DWPC	metapath
Iloprost—SLCO3A1—Methotrexate—testicular cancer	0.656	1	CbGbCtD
Iloprost—PLAT—seminal vesicle—testicular cancer	0.0184	0.0753	CbGeAlD
Iloprost—PTGER1—female gonad—testicular cancer	0.0138	0.0564	CbGeAlD
Iloprost—SLCO3A1—seminal vesicle—testicular cancer	0.0128	0.0524	CbGeAlD
Iloprost—SLCO2A1—seminal vesicle—testicular cancer	0.0127	0.0519	CbGeAlD
Iloprost—PLAT—female gonad—testicular cancer	0.0108	0.0442	CbGeAlD
Iloprost—PTGIR—gonad—testicular cancer	0.0105	0.0429	CbGeAlD
Iloprost—PDE4D—female gonad—testicular cancer	0.00991	0.0405	CbGeAlD
Iloprost—PLAT—testis—testicular cancer	0.00961	0.0392	CbGeAlD
Iloprost—SLCO3A1—gonad—testicular cancer	0.00926	0.0378	CbGeAlD
Iloprost—PDE4D—testis—testicular cancer	0.00879	0.0359	CbGeAlD
Iloprost—PDE4A—female gonad—testicular cancer	0.00877	0.0358	CbGeAlD
Iloprost—PTGIR—female gonad—testicular cancer	0.00853	0.0348	CbGeAlD
Iloprost—PDE4A—testis—testicular cancer	0.00778	0.0318	CbGeAlD
Iloprost—PTGIR—testis—testicular cancer	0.00757	0.0309	CbGeAlD
Iloprost—PLAT—NOTCH1 regulation of human endothelial cell calcification—FGFR3—testicular cancer	0.00755	0.0758	CbGpPWpGaD
Iloprost—SLCO3A1—female gonad—testicular cancer	0.00753	0.0307	CbGeAlD
Iloprost—SLCO2A1—female gonad—testicular cancer	0.00746	0.0305	CbGeAlD
Iloprost—PLAT—lymph node—testicular cancer	0.00697	0.0284	CbGeAlD
Iloprost—SLCO3A1—testis—testicular cancer	0.00668	0.0273	CbGeAlD
Iloprost—SLCO2A1—testis—testicular cancer	0.00661	0.027	CbGeAlD
Iloprost—PDE4B—gonad—testicular cancer	0.00643	0.0263	CbGeAlD
Iloprost—PDE4D—lymph node—testicular cancer	0.00637	0.026	CbGeAlD
Iloprost—PDE4C—G alpha (s) signalling events—INSL3—testicular cancer	0.00605	0.0608	CbGpPWpGaD
Iloprost—SLCO2A1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00583	0.0585	CbGpPWpGaD
Iloprost—PDE4A—lymph node—testicular cancer	0.00564	0.023	CbGeAlD
Iloprost—SLCO3A1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00552	0.0555	CbGpPWpGaD
Iloprost—PTGIR—lymph node—testicular cancer	0.00548	0.0224	CbGeAlD
Iloprost—SLCO2B1—female gonad—testicular cancer	0.00534	0.0218	CbGeAlD
Iloprost—PTGIR—G alpha (s) signalling events—INSL3—testicular cancer	0.00533	0.0536	CbGpPWpGaD
Iloprost—PDE4D—G alpha (s) signalling events—INSL3—testicular cancer	0.00527	0.0529	CbGpPWpGaD
Iloprost—PDE4B—female gonad—testicular cancer	0.00523	0.0214	CbGeAlD
Iloprost—PDE4A—G alpha (s) signalling events—INSL3—testicular cancer	0.00501	0.0504	CbGpPWpGaD
Iloprost—SLCO3A1—lymph node—testicular cancer	0.00484	0.0198	CbGeAlD
Iloprost—SLCO2A1—lymph node—testicular cancer	0.00479	0.0196	CbGeAlD
Iloprost—SLCO2B1—testis—testicular cancer	0.00473	0.0193	CbGeAlD
Iloprost—PDE4B—G alpha (s) signalling events—INSL3—testicular cancer	0.00464	0.0466	CbGpPWpGaD
Iloprost—PDE4B—testis—testicular cancer	0.00464	0.0189	CbGeAlD
Iloprost—PLAT—amb2 Integrin signaling—MMP2—testicular cancer	0.0037	0.0372	CbGpPWpGaD
Iloprost—SLCO2B1—lymph node—testicular cancer	0.00343	0.014	CbGeAlD
Iloprost—PDE4B—lymph node—testicular cancer	0.00336	0.0137	CbGeAlD
Iloprost—SLCO2B1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.0032	0.0322	CbGpPWpGaD
Iloprost—SLCO2A1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.00296	0.0297	CbGpPWpGaD
Iloprost—SLCO3A1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.00281	0.0282	CbGpPWpGaD
Iloprost—PLAT—Endochondral Ossification—FGFR3—testicular cancer	0.00261	0.0263	CbGpPWpGaD
Iloprost—PTGIR—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.00254	0.0255	CbGpPWpGaD
Iloprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.00254	0.0255	CbGpPWpGaD
Iloprost—PLAT—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.00239	0.024	CbGpPWpGaD
Iloprost—PTGIR—GPCR ligand binding—INSL3—testicular cancer	0.00194	0.0194	CbGpPWpGaD
Iloprost—PTGER1—GPCR ligand binding—INSL3—testicular cancer	0.00194	0.0194	CbGpPWpGaD
Iloprost—SLCO2B1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.00163	0.0163	CbGpPWpGaD
Iloprost—PLAT—Signaling by PDGF—KITLG—testicular cancer	0.00152	0.0153	CbGpPWpGaD
Iloprost—PDE4C—GPCR downstream signaling—INSL3—testicular cancer	0.00124	0.0125	CbGpPWpGaD
Iloprost—PLAT—Signaling by PDGF—FGFR3—testicular cancer	0.00113	0.0114	CbGpPWpGaD
Iloprost—PDE4C—Signaling by GPCR—INSL3—testicular cancer	0.00113	0.0113	CbGpPWpGaD
Iloprost—PTGER1—GPCR downstream signaling—INSL3—testicular cancer	0.00109	0.011	CbGpPWpGaD
Iloprost—PTGIR—GPCR downstream signaling—INSL3—testicular cancer	0.00109	0.011	CbGpPWpGaD
Iloprost—PDE4D—GPCR downstream signaling—INSL3—testicular cancer	0.00108	0.0109	CbGpPWpGaD
Iloprost—PLAT—Signaling by PDGF—KIT—testicular cancer	0.00104	0.0104	CbGpPWpGaD
Iloprost—PDE4A—GPCR downstream signaling—INSL3—testicular cancer	0.00103	0.0103	CbGpPWpGaD
Iloprost—PTGER1—Signaling by GPCR—INSL3—testicular cancer	0.000994	0.00998	CbGpPWpGaD
Iloprost—PTGIR—Signaling by GPCR—INSL3—testicular cancer	0.000994	0.00998	CbGpPWpGaD
Iloprost—PDE4D—Signaling by GPCR—INSL3—testicular cancer	0.000982	0.00986	CbGpPWpGaD
Iloprost—PDE4B—GPCR downstream signaling—INSL3—testicular cancer	0.000952	0.00956	CbGpPWpGaD
Iloprost—PDE4A—Signaling by GPCR—INSL3—testicular cancer	0.000934	0.00938	CbGpPWpGaD
Iloprost—PDE4B—Signaling by GPCR—INSL3—testicular cancer	0.000865	0.00868	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—INSL3—testicular cancer	0.000775	0.00778	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—INSL3—testicular cancer	0.000666	0.00669	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—INSL3—testicular cancer	0.000587	0.00589	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—INSL3—testicular cancer	0.000587	0.00589	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—INSL3—testicular cancer	0.00058	0.00582	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—INSL3—testicular cancer	0.000552	0.00554	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—INSL3—testicular cancer	0.000511	0.00513	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—H2AFZ—testicular cancer	0.000248	0.00249	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—STK11—testicular cancer	0.000247	0.00248	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—KITLG—testicular cancer	0.000228	0.00229	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—H2AFZ—testicular cancer	0.000213	0.00214	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—STK11—testicular cancer	0.000212	0.00213	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—KITLG—testicular cancer	0.000196	0.00197	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—H2AFZ—testicular cancer	0.000188	0.00189	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—H2AFZ—testicular cancer	0.000188	0.00189	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—STK11—testicular cancer	0.000187	0.00188	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—STK11—testicular cancer	0.000187	0.00188	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—H2AFZ—testicular cancer	0.000186	0.00186	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—STK11—testicular cancer	0.000185	0.00185	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—H2AFZ—testicular cancer	0.000177	0.00177	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—STK11—testicular cancer	0.000176	0.00176	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—KITLG—testicular cancer	0.000173	0.00174	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—KITLG—testicular cancer	0.000173	0.00174	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—KITLG—testicular cancer	0.000171	0.00171	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—FGFR3—testicular cancer	0.00017	0.0017	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—H2AFZ—testicular cancer	0.000163	0.00164	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—STK11—testicular cancer	0.000163	0.00163	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—KITLG—testicular cancer	0.000163	0.00163	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—KIT—testicular cancer	0.000156	0.00156	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—KITLG—testicular cancer	0.00015	0.00151	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—FGFR3—testicular cancer	0.000146	0.00146	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—KIT—testicular cancer	0.000134	0.00134	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—FGFR3—testicular cancer	0.000128	0.00129	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—FGFR3—testicular cancer	0.000128	0.00129	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—FGFR3—testicular cancer	0.000127	0.00127	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—FGFR3—testicular cancer	0.000121	0.00121	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—KIT—testicular cancer	0.000118	0.00118	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—KIT—testicular cancer	0.000118	0.00118	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—KIT—testicular cancer	0.000117	0.00117	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—FGFR3—testicular cancer	0.000112	0.00112	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—KIT—testicular cancer	0.000111	0.00111	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—KIT—testicular cancer	0.000103	0.00103	CbGpPWpGaD
